Picture of Astria Therapeutics logo

ATXS — Astria Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Catabasis Pharmaceuticals Reports Fourth Quarter And Full Year 2020 Financial Results And Provides A Corporate Update

March 11 (Reuters) - Catabasis Pharmaceuticals Inc  CATB.O :
    * CATABASIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2020 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
    * Q4 LOSS PER SHARE $0.45

Source text for Eikon:  ID:nBw7P2pWja 
Further company coverage:  CATB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Astria Therapeutics

See all news